RPS7 Gene
Introduction
The RPS7 gene encodes Ribosomal Protein S7, a core component of the 40S small ribosomal subunit essential for eukaryotic protein synthesis. Beyond its canonical role in translation, RPS7 has emerged as a critical tumor suppressor protein through its interaction with MDM2 and p53. Mutations in RPS7 are associated with Diamond-Blackfan anemia (DBA), a congenital bone marrow failure syndrome, and contribute to the understanding of ribosomopathies and cancer biology.
<div class="infobox infobox-gene">
<h3>RPS7</h3>
<table>
<tr><th>Full Name</th><td>Ribosomal Protein S7</td></tr>
<tr><th>Gene Symbol</th><td>RPS7</td></tr>
<tr><th>Chromosomal Location</th><td>2p25.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[6205](https://www.ncbi.nlm.nih.gov/gene/6205)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000171863](https://www.ensembl.org/Homo_sapiens/ENSG00000171863)</td></tr>
<tr><th>UniProt ID</th><td>[P62081](https://www.uniprot.org/uniprot/P62081)</td></tr>
<tr><th>Protein Length</th><td>194 amino acids</td></tr>
<tr><th>Protein Molecular Weight</th><td>~22.5 kDa</td></tr>
<tr><th>Associated Diseases</th><td>[Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia), [Cancer](/diseases/cancer), [Ribosomopathies](/diseases/ribosomopathy)</td></tr>
</table>
</div>
Gene Structure and Evolution
The RPS7 gene is located on chromosome 2p25.3 and encodes a protein of 194 amino acids. RPS7 is highly conserved across eukaryotes, reflecting its essential role in cellular function.
...RPS7 Gene
Introduction
The RPS7 gene encodes Ribosomal Protein S7, a core component of the 40S small ribosomal subunit essential for eukaryotic protein synthesis. Beyond its canonical role in translation, RPS7 has emerged as a critical tumor suppressor protein through its interaction with MDM2 and p53. Mutations in RPS7 are associated with Diamond-Blackfan anemia (DBA), a congenital bone marrow failure syndrome, and contribute to the understanding of ribosomopathies and cancer biology.
<div class="infobox infobox-gene">
<h3>RPS7</h3>
<table>
<tr><th>Full Name</th><td>Ribosomal Protein S7</td></tr>
<tr><th>Gene Symbol</th><td>RPS7</td></tr>
<tr><th>Chromosomal Location</th><td>2p25.3</td></tr>
<tr><th>NCBI Gene ID</th><td>[6205](https://www.ncbi.nlm.nih.gov/gene/6205)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000171863](https://www.ensembl.org/Homo_sapiens/ENSG00000171863)</td></tr>
<tr><th>UniProt ID</th><td>[P62081](https://www.uniprot.org/uniprot/P62081)</td></tr>
<tr><th>Protein Length</th><td>194 amino acids</td></tr>
<tr><th>Protein Molecular Weight</th><td>~22.5 kDa</td></tr>
<tr><th>Associated Diseases</th><td>[Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia), [Cancer](/diseases/cancer), [Ribosomopathies](/diseases/ribosomopathy)</td></tr>
</table>
</div>
Gene Structure and Evolution
The RPS7 gene is located on chromosome 2p25.3 and encodes a protein of 194 amino acids. RPS7 is highly conserved across eukaryotes, reflecting its essential role in cellular function.
RPS7 is a member of the ribosomal protein S7 family, which includes multiple paralogs in mammals. The protein structure includes:
- An N-terminal domain that interacts with 18S rRNA
- A central domain critical for binding translation factors
- A C-terminal domain that participates in the decoding center of the ribosome
Normal Cellular Function
Role in Translation
RPS7 is an essential component of the 40S ribosomal subunit:
Ribosome Assembly: RPS7 is required for proper 40S subunit assembly and 18S rRNA processing
Translation Initiation: RPS7 interacts with eIF3 and other initiation factors, facilitating the formation of the pre-initiation complex
mRNA Scanning: The 40S subunit with RPS7 performs the scanning process to locate the start codon
Accuracy of Translation: RPS7 contributes to translational fidelityThe RPS7-MDM2-p53 Pathway
One of the most important extra-ribosomal functions of RPS7 is its role in the MDM2-p53 tumor suppressor pathway:
MDM2 Binding: RPS7 binds to MDM2, the major E3 ubiquitin ligase responsible for p53 degradation
p53 Stabilization: By binding MDM2, RPS7 inhibits p53 ubiquitination and degradation
p53 Activation: Stabilized p53 activates its transcriptional programs
Cell Cycle Control: p53 induces cell cycle arrest, DNA repair, or apoptosisThis pathway provides a direct link between ribosomal function and tumor suppression [@De_2010].
RPS7 as a Tumor Suppressor
The RPS7-MDM2-p53 axis positions RPS7 as a critical tumor suppressor:
- Ribosomal Stress Response: When ribosome assembly is impaired, excess RPS7 binds MDM2
- p53-Dependent Apoptosis: This leads to p53 activation and removal of cells with ribosomal defects
- Prevention of Transformation: The pathway prevents the accumulation of cells with genomic instability
Expression Patterns
RPS7 is ubiquitously expressed, with highest levels in:
- Bone marrow: Active hematopoiesis requires high protein synthesis
- Proliferating cells: Cell division requires increased translational capacity
- Brain: High metabolic activity in neural tissue
- Testis: Spermatogenesis involves rapid cell division
In the brain, RPS7 is expressed in neurons and glial cells, contributing to synaptic protein synthesis and neuronal homeostasis.
Disease Associations
Diamond-Blackfan Anemia (DBA)
DBA is a congenital bone marrow failure syndrome characterized by:
- Pure red cell aplasia
- Variable congenital anomalies
- Increased risk of hematological malignancies
- Mutations in ribosomal protein genes
RPS7 mutations account for approximately 1-2% of DBA cases. The pathogenic mechanism involves:
Haploinsufficiency: Reduced RPS7 protein levels
Ribosome Biogenesis Defects: Impaired 40S subunit assembly
Ribosomal Stress: Activation of the RPS7-MDM2-p53 pathway
Erythroid Precursor Apoptosis: Selective death of erythroid progenitorsCancer
RPS7 functions as a tumor suppressor:
Direct Interaction with MDM2: RPS7 inhibits MDM2-mediated p53 degradation
p53 Activation: This leads to p53-dependent cell cycle arrest or apoptosis
Prevention of Genomic Instability: The pathway prevents accumulation of mutationsLoss of RPS7 function contributes to:
- Acute myeloid leukemia (AML)
- Various solid tumors
- Tumor progression
Ribosomopathies
RPS7 mutations are associated with the spectrum of ribosomopathies:
Ribosome Biogenesis Impairment: Defective 40S assembly
Translation Dysregulation: Reduced translational capacity
Cellular Stress: Activation of stress response pathwaysThe tissue-specific manifestations reflect differential sensitivity to ribosomal stress.
Molecular Mechanisms
The RPS7-MDM2-p53 Tumor Suppressor Axis
The RPS7-MDM2-p53 pathway is a critical cellular defense mechanism:
Under Normal Conditions: MDM2 continuously ubiquitinates p53, maintaining low p53 levels
Upon Ribosomal Stress: Unassembled RPS7 accumulates in the cytoplasm
MDM2 Inhibition: RPS7 binds to MDM2, blocking its E3 ligase activity
p53 Stabilization: p53 levels increase, activating tumor suppressor programs
Cell Fate Decisions: p53 induces cell cycle arrest, senescence, or apoptosisThis pathway connects ribosomal function to cell fate decisions, providing a tumor suppressor mechanism that eliminates cells with ribosomal defects.
Implications for Neurodegeneration
Ribosomal dysfunction, including RPS7 dysfunction, contributes to neurodegeneration:
Translation Defects: Impaired protein synthesis affects synaptic function
Proteostasis Impairment: Reduced capacity for protein quality control
Stress Pathway Activation: Chronic ribosomal stress may lead to neuronal death
Synaptic Protein Deficits: Impaired synthesis of proteins required for synaptic functionTherapeutic Implications
Cancer Therapy
The RPS7-MDM2-p53 pathway is being exploited for cancer therapy:
MDM2 Inhibitors: Drugs like nutlin-3 and idasanutlin reactivates p53 in tumors with wild-type p53
Ribosome-Targeting Agents: Compounds that selectively affect rapidly dividing cancer cells
Combination Therapies: MDM2 inhibitors with other agentsDBA Treatment
DBA treatment strategies include:
Corticosteroids: First-line therapy
Transfusion Support: For transfusion-dependent patients
Stem Cell Transplantation: Curative approach
Emerging Therapies: Targeting the ribosomal stress pathwayResearch Directions
Key areas for future research:
RPS7 mutations in cancer and DBA
Post-translational modifications of RPS7
RPS7-based biomarkers for disease
Therapeutic targeting of the RPS7 pathwaySee Also
- [Ribosomal Protein S7 (RPS7) Protein](/proteins/rps7-protein)
- [Ribosome Biogenesis Pathway](/mechanisms/ribosome-biogenesis)
- [Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia)
- [MDM2-p53 Pathway](/mechanisms/mdm2-p53-pathway)
- [Ribosomopathies](/mechanisms/ribosomopathies)
- [Ribosomal Dysfunction in Neurodegeneration](/mechanisms/ribosome-dysfunction-neurodegeneration)
References
[Diamond-Blackfan anemia: 20 years of progress (2021)](https://doi.org/10.1182/blood.2020009016)
[Ribosomal proteins in DBA (2020)](https://doi.org/10.1182/blood.2020009015)
[RPS7 and p53 activation (2020)](https://doi.org/10.1038/s41418-019-0347-0)
[Ribosomal protein L5 and L11 mutations in DBA (2008)](https://doi.org/10.1016/j.ajhg.2008.11.006)
[Ribosomal proteins: functions beyond the ribosome (2015)](https://doi.org/10.1093/jmcb/mjv014)
[Diamond Blackfan anemia: ribosomal proteins going wrong (2010)](https://doi.org/10.1038/nrc2943)
[Ribosomal proteins and molecular signatures of ribosomopathies (2012)](https://doi.org/10.1007/s00018-012-1061-x)
[Hsp90 inhibition and RPL5/RPL11-dependent p53 activation (2010)](https://doi.org/10.1016/j.febslet.2010.11.015)
[Ribosome biogenesis in disease (2020)](https://doi.org/10.1038/s41580-020-0217-0)External Links
- [NCBI Gene: RPS7](https://www.ncbi.nlm.nih.gov/gene/6205)
- [UniProt: RS7_HUMAN](https://www.uniprot.org/uniprot/P62081)
- [Ensembl: RPS7](https://www.ensembl.org/Homo_sapiens/ENSG00000171863)
- [Allen Brain Atlas: RPS7 Expression](https://human.brain-map.org/microarray/search/show?search_term=RPS7)